2025.04.28 (월)

  • 맑음동두천 10.6℃
  • 흐림강릉 18.8℃
  • 구름많음서울 12.8℃
  • 흐림대전 15.4℃
  • 흐림대구 16.4℃
  • 맑음울산 18.6℃
  • 구름많음광주 16.6℃
  • 구름많음부산 16.7℃
  • 흐림고창 12.5℃
  • 제주 15.2℃
  • 맑음강화 10.8℃
  • 흐림보은 10.7℃
  • 흐림금산 14.5℃
  • 흐림강진군 15.3℃
  • 구름많음경주시 15.7℃
  • 흐림거제 16.9℃
기상청 제공

경제

Quintiles Advances Risk-based Monitoring with the Launch of Data-driven Trial Execution Powered by Infosario™ Clinical

[By NBC-1TV H. J Yook]Quintiles today announced the launch of its comprehensive, fully-integrated Data-driven Trial Execution offering, which leverages the concept of risk-based monitoring to improve clinical trial delivery. While the industry’s current approach to risk-based monitoring focuses solely on clinical trial monitoring, Data-driven Trial Execution combines study start-up, project management, clinical monitoring, data management and analytics to optimize trial conduct while meeting regulatory demands and quality requirements for Good Clinical Practice (GCP).

“Our customers are seeking to manage clinical trials with greater efficiency, seamless execution and predictive insights that enable them to respond faster and make better-informed decisions,” said Paula Brown Stafford, president of Clinical Development at Quintiles. “Data-driven Trial Execution is the first in a series of standardized offerings that Quintiles plans to bring to market, and is our answer to optimized trial execution that has the potential to improve quality while reducing overall trial costs by up to 25 percent.”



배너

관련기사


배너
배너
배너
배너
배너
배너
배너
배너
배너
배너
배너
배너